BOSTON SCIENTIFIC CORPORATION Deferred Tax Assets, Tax Deferred Expense
BOSTON SCIENTIFIC CORPORATION (BSX) had Deferred Tax Assets, Tax Deferred Expense of $5.03 billion as of 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2024-02-20
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense $5.03B.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense $4.95B.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense $4.93B.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense $4.67B.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2023-12-31 | $5.03B 10-K · filed 2024-02-20 |
| 2022-12-31 | $4.95B 10-K · filed 2024-02-20 |
| 2021-12-31 | $4.93B 10-K · filed 2023-02-23 |
| 2020-12-31 | $4.67B 10-K · filed 2022-02-23 |
| 2019-12-31 | $4.61B 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |